Dualitas Therapeutics

Private

South San Francisco biotech pioneering next-generation bispecific antibodies for immunology and inflammation using its DualScreen bispecific discovery engine.

Company Info

Sector:Biotechnology / Bispecific Antibodies

Headquarters:South San Francisco, California, USA

Founded:2024

Website:www.dualitastx.com/

Funding Round:Series A

Total Funding:~$5M

Funding & Investor Relations

Notable Investors

Undisclosed

IPO Outlook / Plans

Private; no announced IPO timeline

Clinical Development Pipeline

Undisclosed bispecific antibodies

Target: Undisclosed

Immune and inflammatory diseases

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Recent News

No recent news updates available for this company.

Leadership Team

Careers & Job Openings

See all open roles

Careers

South San Francisco, CA

Apply Now →